SAM
NUVB icon

Smartleaf Asset Management’s Nuvation Bio NUVB Stock Holding History

Smartleaf Asset Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$834 Buy
+206
New +$1.15K ﹤0.01% 3149

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Smartleaf Asset Management's NUVB Position: Q1 2026 in Review

Smartleaf Asset Management opened a new position in Nuvation Bio (NUVB) in Q1 2026: 206 shares worth $834. The stake represents ﹤0.01% of the portfolio and ranks #3149 among its holdings.

231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Smartleaf Asset Management held 206 shares of Nuvation Bio worth $834 as of Q1 2026.
  • Nuvation Bio was a new Smartleaf Asset Management position in Q1 2026.
  • Nuvation Bio made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q1 2026, its #3149 holding.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.